FDA Safety Reports – Tasigna (Nilotinib), Cardiac Disorders

FDA Safety Reports – Tasigna (Nilotinib), Cardiac Disorders

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Original Request: Product: Tasigna (Nilotinib) Cardiac disorders OR Heart Failure AND Sudden Deaths OR Death OR Fatal, Period: 01-Jan1900 - 16-October-2024
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details